Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mitesco (MITI) Research & Development (2025)

Mitesco (MITI) has disclosed Research & Development for 6 consecutive years, with $1100.0 as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development changed N/A to $1100.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $209172.0, a N/A change, with the full-year FY2014 number at $892092.0, up 6.34% from a year prior.
  • Research & Development was $1100.0 for Q3 2025 at Mitesco, down from $21122.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $21122.0 in Q2 2025 to a low of $1100.0 in Q3 2025.